Sustainability Edge Future Fields operates a green-certified biomanufacturing platform using whole fruit flies, aligning with buyers seeking sustainable, ethical, and cost-effective protein production solutions in biotech and food/agri sectors.

Strategic funding Recent $8M Series A funding and active investors (BDC Capital, R72 Partners, Amplify Capital) indicate growing validation and potential for partnerships and co-development deals with scale-focused biomanufacturers and life science customers.

Productivity leap Instar 1.0 launch claims thirtyfold output improvement over conventional protein tech, presenting a strong value proposition for CDMO partnerships and contract work needing higher-throughput, lower-cost production.

AI collaboration Partnership with Protein Evolution to develop AI-engineered proteins signals opportunities to cross-sell AI-driven design services, immunogenicity assessments, and custom protein engineering for pharma and biotech clients.

Expansion opportunities As a Canada-based biotech with a growing platform and CDMO capabilities, there are potential sales angles with regional biotech clusters, academic partnerships, and green-certified labs seeking scalable, sustainable manufacturing partners.